226
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Cannabis-induced psychosis presenting to a psychiatric emergency department: a case series

ORCID Icon &
Pages 448-451 | Received 05 Feb 2021, Accepted 09 Aug 2021, Published online: 17 Aug 2021

References

  • Alderson, H. L., Semple, D. M., Blayney, C., Queirazza, F., Chekuri, V., & Lawrie, S. M. (2017). Risk of transition to schizophrenia following first admission with substance-induced psychotic disorder: A population-based longitudinal cohort study. Psychological Medicine, 47(14), 2548–2555. https://doi.org/10.1017/S0033291717001118
  • Carliner, H., Brown, Q. L., Sarvet, A. L., & Hasin, D. S. (2017). Cannabis use, attitudes, and legal status in the U.S.: A review. Preventive Medicine, 104, 13–23. https://doi.org/10.1016/j.ypmed.2017.07.008
  • Curtis, L., Rey-Bellet, P., & Merlo, M. C. G. (2006). [Cannabis and psychosis]. Revue medicale suisse, 2(79), 2099–2100,2102-2103. https://www.revmed.ch/revue-medicale-suisse/2006/revue-medicale-suisse-79/cannabis-et-psychose#tab=tab-toc
  • D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction. Biological Psychiatry, 57(6), 594–608. https://doi.org/10.1016/j.biopsych.2004.12.006
  • Dean, B., Sundram, S., Bradbury, R., Scarr, E., & Copolov, D. (2001). Studies on [3H]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience, 103(1), 9–15. https://doi.org/10.1016/s0306-4522(00)00552-2
  • Degenhardt, L., Tennant, C., Gilmour, S., Schofield, D., Nash, L., Hall, W., & McKay, D. (2007). The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: Findings from a 10-month prospective study. Psychological Medicine, 37(7), 927–934. https://doi.org/10.1017/S0033291707009956
  • Dellazizzo, L., Potvin, S., Athanassiou, M., & Dumais, A. (2020). Violence and Cannabis use: A focused review of a forgotten aspect in the era of liberalizing Cannabis. Frontiers in Psychiatry, 11(September), 1–11. https://doi.org/10.3389/fpsyt.2020.567887
  • Gorfinkel, L. R., Stohl, M., & Hasin, D. (2020). Association of depression with past-month Cannabis use among us adults aged 20 to 59 years, 2005 to 2016. JAMA Network Open, 3(8), e2013802. https://doi.org/10.1001/jamanetworkopen.2020.13802
  • Häfner, H. (2005). Psychosis and cannabis. Archives of Clinical Psychiatry (São Paulo), 32(2), 53–67. https://doi.org/10.1590/s0101-60832005000200001
  • Hall, W., & Degenhardt, L. (2000). Cannabis use and psychosis: A review of clinical and epidemiological evidence. The Australian and New Zealand Journal of Psychiatry, 34(1), 26–34. https://doi.org/10.1046/j.1440-1614.2000.00685.x
  • Hasin, D. S., Sarvet, A. L., Cerdá, M., Keyes, K. M., Stohl, M., Galea, S., & Wall, M. M. (2017). US adult illicit Cannabis use, Cannabis use disorder, and medical Marijuana laws: 1991-1992 to 2012-2013. JAMA Psychiatry, 74(6), 579–588. https://doi.org/10.1001/jamapsychiatry.2017.0724
  • Hussain, S. A., Zhou, R., Jacobson, C., Weng, J., Cheng, E., Lay, J., Hung, P., Lerner, J. T., & Sankar, R. (2015). Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome. Epilepsy & Behavior, 47, 138–141. https://doi.org/10.1016/j.yebeh.2015.04.009
  • Jager, G., Block, R. I., Luijten, M., & Ramsey, N. F. (2010). Cannabis use and memory brain function in adolescent boys: A cross-sectional multicenter functional magnetic resonance imaging study. Journal of the American Academy of Child and Adolescent Psychiatry, 49(6), 561–572, 572.e1-3. https://doi.org/10.1016/j.jaac.2010.02.001
  • Johns, A. (2001). Psychiatric effects of cannabis. British Journal of Psychiatry, 178(2), 116–122. https://doi.org/10.1192/bjp.178.2.116
  • Kendler, K. S., Ohlsson, H., Sundquist, J., & Sundquist, K. (2019). Prediction of onset of substance-induced psychotic disorder and its progression to Schizophrenia in a Swedish national sample. The American Journal of Psychiatry, 176(9), 711–719. https://doi.org/10.1176/appi.ajp.2019.18101217
  • Lee, T. Y., & Kwon, J. S. (2016). Psychosis research in Asia: Advantage from low prevalence of cannabis use. Npj Schizophrenia, 2(1), 0–1. https://doi.org/10.1038/s41537-016-0002-4
  • Linszen, D., & Van Amelsvoort, T. (2007). Cannabis and psychosis: An update on course and biological plausible mechanisms. Current Opinion in Psychiatry, 20(2), 116–120. https://doi.org/10.1097/YCO.0b013e32803577fb
  • Mathers, D. C., & Ghodse, A. H. (1992). Cannabis and psychotic illness. The British Journal of Psychiatry : The Journal of Mental Science, 161(5), 648–653. https://doi.org/10.1192/bjp.161.5.648
  • McGuire, P. K., Jones, P., Harvey, I., Bebbington, P., Toone, B., Lewis, S., & Murray, R. M. (1994). Cannabis and acute psychosis. Schizophrenia Research, 13(2), 161–167. https://doi.org/10.1016/0920-9964(94)90097-3
  • The Ministry of Justice, R. O. C. (2019). Illicit drug abuse on campus: Annual reports. https://antidrug.moj.gov.tw/cp-186-6307-1.html
  • The Ministry of Justice, R. O. C. (2020a). Statistics on drug abuse cases and examinations in 2019. https://antidrug.moj.gov.tw/cp-89-6792-2.html
  • The Ministry of Justice, R. O. C. (2020b). Statistics on drug abuse cases and examinations in July 2020. https://antidrug.moj.gov.tw/cp-89-6799-2.html
  • Niemi-Pynttäri, J. A., Sund, R., Putkonen, H., Vorma, H., Wahlbeck, K., & Pirkola, S. P. (2013). Substance-induced psychoses converting into schizophrenia: A register-based study of 18,478 Finnish inpatient cases. The Journal of Clinical Psychiatry, 74(1), e94–9. https://doi.org/10.4088/JCP.12m07822
  • Price, C., Hemmingsson, T., Lewis, G., Zammit, S., & Allebeck, P. (2009). Cannabis and suicide: Longitudinal study. British Journal of Psychiatry, 195(6), 492–497. https://doi.org/10.1192/bjp.bp.109.065227
  • Rabin, R. A., & George, T. P. (2017). Understanding the link between cannabinoids and psychosis. Clinical Pharmacology and Therapeutics, 101(2), 197–199. https://doi.org/10.1002/cpt.421
  • Rong, C., Lee, Y., Carmona, N. E., Cha, D. S., Ragguett, R.-M., Rosenblat, J. D., Mansur, R. B., Ho, R. C., & McIntyre, R. S. (2017). Cannabidiol in medical Marijuana: Research vistas and potential opportunities. Pharmacological Research, 121, 213–218. https://doi.org/10.1016/j.phrs.2017.05.005
  • Russo, E. B., & Marcu, J. (2017). Cannabis pharmacology: The usual suspects and a few promising leads. Advances in Pharmacology, 80, 67–134. https://doi.org/10.1016/bs.apha.2017.03.004
  • Shrivastava, A., Johnston, M., Terpstra, K., & Bureau, Y. (2014). Cannabis and psychosis: Neurobiology. Indian Journal of Psychiatry, 56(1), 8–16. https://doi.org/10.4103/0019-5545.124708
  • Starzer, M. S. K., Nordentoft, M., & Hjorthøj, C. (2018). Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis. The American Journal of Psychiatry, 175(4), 343–350. https://doi.org/10.1176/appi.ajp.2017.17020223
  • Stefanis, N. C., Delespaul, P., Henquet, C., Bakoula, C., Stefanis, C. N., & VanOs, J. (2004). Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction (Abingdon, England), 99(10), 1333–1341. https://doi.org/10.1111/j.1360-0443.2004.00806.x
  • The United Nations Office on Drugs and Crime. (2020). The World Drug Report Booklet 3: Drug Supply. https://doi.org/10.1002/9781118422878.ch42
  • Zammit, S., Moore, T. H. M., Lingford-Hughes, A., Barnes, T. R. E., Jones, P. B., Burke, M., & Lewis, G. (2008). Effects of cannabis use on outcomes of psychotic disorders: Systematic review. The British Journal of Psychiatry : The Journal of Mental Science, 193(5), 357–363. https://doi.org/10.1192/bjp.bp.107.046375

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.